Hub : Traits :

Primary Biliary Cirrhosis

152 significantly associated models · 41 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	67074053	68559650	1	1	3.3e-21	7.5e-28	2.0e-08	74	IL12RB2
2	1	196798989	198436809	1	1	1.9e-09	1.0e-11	1.1e-03	77	DENND1B
3	2	190521054	191931464	1	1	4.1e-10	2.3e-14	1.2e-05	67	INPP1
4	3	118779507	119458851	2	2	4.2e-09	4.3e-15	1.3e-05	69	ARHGAP31 KTELC1
5	3	159013779	160970437	5	7	1.7e-22	1.4e-23	NaN	NaN	IL12A KPNA4 SMC4 TRIM59
6	4	258627	1694809	3	1	1.2e-07	2.7e-07	7.0e-02	88	SLC26A1
7	4	102852939	104627833	4	1	8.2e-10	8.2e-10	1.0e+00	100	SLC9B1
8	5	35608310	36124514	1	1	4.5e-09	4.7e-11	1.7e-03	77	IL7R
9	7	127878155	129284182	2	2	2.2e-23	5.1e-23	4.2e-04	87	IRF5
10	11	63316786	64820283	2	1	2.8e-09	1.7e-09	1.5e-01	94	CCDC88B
11	11	118365263	119765318	2	1	2.0e-10	1.1e-13	1.1e-04	73	DDX6
12	12	111154626	112582540	1	1	1.4e-07	3.2e-08	3.5e-03	72	SH2B3
13	15	78520204	79933757	1	1	2.4e-07	1.6e-07	1.0e+00	100	CTSH
14	16	10329905	12138068	4	2	6.6e-14	2.4e-14	1.0e+00	100	DEXI RMI2
15	17	37101380	39048774	8	1	3.2e-11	2.6e-11	1.0e-01	94	GSDMB
16	19	10283932	11730690	1	1	2.0e-07	1.0e-10	5.0e-10	7	CARM1
17	22	39064209	40479448	1	1	6.7e-12	2.2e-11	4.4e-01	99	SYNGR1

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Blood Eosinophil Count	12.05	10	6	13.3	0.28	0.39726	CARM1 CCDC88B DDX6 DENND1B DEXI GSDMB IL7R IRF5 SH2B3 SLC9B1
Mouth/teeth dental problems: Mouth ulcers	11.34	10	6	13.3	-0.55	0.05026	DENND1B IL12A IL12RB2 IL7R IRF5 KPNA4 SH2B3 SLC9B1 SMC4 TRIM59
Lupus	10.85	5	1	2.2	0.92	0.00976	DEXI GSDMB IL12A IL12RB2 IRF5
Blood White Count	8.95	7	2	4.4	0.13	0.78375	CARM1 DDX6 DEXI GSDMB IL7R SH2B3 SLC9B1
Hypothyroidism (self reported)	8.47	7	3	6.7	0.67	0.07106	CCDC88B IL12A IL12RB2 IL7R IRF5 SH2B3 SYNGR1
Allergy	8.26	6	5	11.1	-0.10	0.85630	ARHGAP31 DDX6 DEXI GSDMB IL7R SLC9B1
Asthma (self-reported)	7.68	5	3	6.7	0.18	0.76933	CARM1 DDX6 DEXI GSDMB IL7R
Asthma	7.62	5	3	6.7	0.15	0.81051	CARM1 DDX6 DEXI GSDMB IL7R
Hayfever, allergic rhinitis or eczema	7.46	5	4	8.9	0.23	0.70730	DDX6 DEXI GSDMB IL7R SLC9B1
Allergy or Eczema	7.32	6	4	8.9	0.18	0.73297	DDX6 DEXI GSDMB IL7R SH2B3 SLC9B1
Respiratory disease	7.17	3	3	6.7	0.00	1.00000	DEXI GSDMB IL7R
Hypothyroidism/myxoedema (self-reported)	7.01	5	1	2.2	0.71	0.18317	CCDC88B IL7R IRF5 SH2B3 SYNGR1
Medication: Levothyroxine sodium	6.43	3	1	2.2	0.00	1.00000	CCDC88B IL7R SH2B3
Rheumatoid Arthritis	5.13	4	1	2.2	0.99	0.00725	DDX6 GSDMB SH2B3 SYNGR1
Hayfever/allergic rhinitis (self-reported)	4.73	3	2	4.4	0.00	1.00000	DEXI GSDMB IL7R
Irritable Bowel Disease (IBD)	4.57	7	4	8.9	0.65	0.11556	CCDC88B DENND1B GSDMB IL12RB2 IRF5 RMI2 SYNGR1
LDL Cholesterol	4.53	3	1	2.2	0.00	1.00000	CARM1 SH2B3 TRIM59
Medication: Ventolin 100micrograms inhaler	4.28	2	1	2.2	0.00	1.00000	DEXI GSDMB
Number of self-reported non-cancer illnesses	4.17	4	2	4.4	0.61	0.27378	GSDMB KPNA4 SH2B3 TRIM59
Ulcerative Colitis (UC)	3.88	5	1	2.2	0.60	0.20360	GSDMB IL12RB2 IRF5 SLC9B1 SYNGR1
Crohns Disease (2017)	3.84	6	3	6.7	0.65	0.15829	CCDC88B DENND1B GSDMB IL12RB2 RMI2 SYNGR1
Systolic Blood Pressure	3.74	4	4	8.9	0.98	0.00036	KPNA4 SH2B3 SMC4 TRIM59
Taking other prescription medications	3.72	2	1	2.2	0.00	1.00000	GSDMB SH2B3
Cardiovascular Disease	3.62	7	2	4.4	0.81	0.01577	CARM1 CCDC88B KPNA4 SH2B3 SLC26A1 SMC4 TRIM59
Diastolic blood pressure, automated reading	3.30	2	1	2.2	0.00	1.00000	INPP1 SH2B3
Number of treatments/medications taken	3.28	2	1	2.2	0.00	1.00000	SH2B3 TRIM59
Wheeze or whistling in the chest in last year	3.28	2	2	4.4	0.00	1.00000	DEXI GSDMB
Cholesterol lowering medication	3.21	2	1	2.2	0.00	1.00000	CARM1 SLC26A1
High blood pressure	3.15	3	1	2.2	1.00	0.00349	KPNA4 SH2B3 TRIM59
Ulcerative Colitis	3.14	3	1	2.2	0.00	1.00000	GSDMB IL12RB2 IRF5
Medication: Blood pressure	3.09	1	1	2.2	0.00	1.00000	SH2B3
Vascular/heart problems diagnosed by doctor	3.09	2	1	2.2	0.00	1.00000	SH2B3 TRIM59
Medication: Allopurinol	3.08	2	0	0.0	0.00	1.00000	CCDC88B SH2B3
High cholesterol (Self-reported)	3.08	1	1	2.2	0.00	1.00000	CARM1
Gout (self-reported)	3.05	3	0	0.0	0.00	1.00000	CCDC88B IRF5 SH2B3
Systolic blood pressure, automated reading	3.01	5	2	4.4	0.87	0.02579	KPNA4 SH2B3 SLC26A1 SMC4 TRIM59
Crohns Disease (2012)	2.98	4	0	0.0	0.38	0.61698	CCDC88B GSDMB IL12RB2 RMI2
Hypertension (Self-reported)	2.92	2	1	2.2	0.00	1.00000	SH2B3 TRIM59
Medication for cholesterol	2.68	1	1	2.2	0.00	1.00000	SH2B3
Fasting Glucose	2.58	1	0	0.0	0.00	1.00000	SLC9B1
Birth weight of first child	2.57	1	1	2.2	0.00	1.00000	SH2B3
Medication for cholesterol, blood pressure or diabetes	2.56	2	1	2.2	0.00	1.00000	CARM1 SH2B3
Suffer from 'nerves'	2.55	2	0	0.0	0.00	1.00000	SMC4 TRIM59
Ever used hormone-replacement therapy (HRT)	2.49	1	0	0.0	0.00	1.00000	TRIM59
Prostate Cancer	2.37	1	0	0.0	0.00	1.00000	TRIM59
Illnesses of mother	2.35	1	0	0.0	0.00	1.00000	TRIM59
Medication: Simvastatin	2.24	1	1	2.2	0.00	1.00000	CARM1
Mouth/teeth dental problems: Dentures	2.20	1	0	0.0	0.00	1.00000	GSDMB
Pain experienced in last month	2.20	1	0	0.0	0.00	1.00000	SH2B3
Mouth/teeth dental problems	2.19	1	0	0.0	0.00	1.00000	IRF5
Diabetes diagnosed by doctor	2.17	1	0	0.0	0.00	1.00000	TRIM59
Medication: Atenolol	2.16	1	1	2.2	0.00	1.00000	SH2B3
Blood Platelet Count	2.13	9	5	11.1	0.25	0.52456	GSDMB INPP1 IRF5 KPNA4 RMI2 SH2B3 SMC4 SYNGR1 TRIM59
HDL Cholesterol	2.02	2	1	2.2	0.00	1.00000	GSDMB SYNGR1
Reaction Time	2.00	2	1	2.2	0.00	1.00000	CARM1 SH2B3
Diabetes (self-reported)	2.00	1	0	0.0	0.00	1.00000	TRIM59
Heel bone mineral density (BMD) T-score, automated (right)	1.98	2	0	0.0	0.00	1.00000	DDX6 KPNA4
Alcohol intake frequency.	1.97	2	0	0.0	0.00	1.00000	SLC9B1 TRIM59
Fed-up feelings	1.96	2	1	2.2	0.00	1.00000	CCDC88B SH2B3
Illnesses of siblings	1.82	1	0	0.0	0.00	1.00000	SH2B3
Medication: Seretide 50 evohaler	1.82	2	0	0.0	0.00	1.00000	DEXI GSDMB
Illnesses of father: None of the above (group 1)	1.81	1	0	0.0	0.00	1.00000	SH2B3
Heel bone mineral density (BMD) T-score, automated (left)	1.77	1	0	0.0	0.00	1.00000	DDX6
Medication: Blood pressure	1.75	1	1	2.2	0.00	1.00000	SH2B3
Alzheimer’s Disease (in mother)	1.73	2	0	0.0	0.00	1.00000	CTSH SLC26A1
Number of children fathered	1.73	1	0	0.0	0.00	1.00000	DENND1B
Type 2 Diabetes (T2D) (2018)	1.72	2	0	0.0	0.00	1.00000	SH2B3 TRIM59
Other serious medical condition/disability diagnosed by doctor	1.71	1	0	0.0	0.00	1.00000	DEXI
Father's age at death	1.70	1	1	2.2	0.00	1.00000	SH2B3
Knee pain experienced in last month	1.68	1	0	0.0	0.00	1.00000	DEXI
Number of live births	1.66	1	0	0.0	0.00	1.00000	SLC9B1
Heart attack/myocardial infarction (self-reported)	1.66	1	0	0.0	0.00	1.00000	SH2B3
Mean time to correctly identify matches	1.65	1	1	2.2	0.00	1.00000	SH2B3
Blood Red Count	1.64	4	1	2.2	0.08	0.88213	KPNA4 SH2B3 SLC9B1 TRIM59
Coronary Artery Disease (CAD)	1.63	1	0	0.0	0.00	1.00000	SH2B3
Alzheimer’s Disease (including proxy)	1.62	1	0	0.0	0.00	1.00000	SLC26A1
Ever had prostate specific antigen (PSA) test	1.62	1	0	0.0	0.00	1.00000	SLC26A1
Chronotype (morning person)	1.61	2	0	0.0	0.00	1.00000	IL12RB2 KPNA4
Overall health rating	1.61	1	0	0.0	0.00	1.00000	TRIM59
Smoking status: Previous	1.56	1	0	0.0	0.00	1.00000	SH2B3
Heart attack	1.55	1	0	0.0	0.00	1.00000	SH2B3
Qualifications: College or University degree	1.55	4	0	0.0	-1.00	0.00155	CCDC88B KPNA4 SMC4 TRIM59
Medication: Amlodipine	1.54	1	0	0.0	0.00	1.00000	SLC26A1
Comparative body size at age 10	1.54	1	0	0.0	0.00	1.00000	TRIM59
Pulse wave Arterial Stiffness index	1.50	1	0	0.0	0.00	1.00000	CCDC88B
Exposure to tobacco smoke outside home	1.47	1	0	0.0	0.00	1.00000	SH2B3
Medication: Aspirin	1.45	1	0	0.0	0.00	1.00000	SH2B3
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.45	1	1	2.2	0.00	1.00000	GSDMB
Medication: Bendroflumethiazide	1.45	1	0	0.0	0.00	1.00000	SH2B3
Past tobacco smoking	1.43	2	0	0.0	0.00	1.00000	CCDC88B SH2B3
Impedance of arm (left)	1.41	2	1	2.2	0.00	1.00000	SH2B3 SLC9B1
Pulse wave peak to peak time	1.41	1	0	0.0	0.00	1.00000	CCDC88B
Seen doctor (GP) for nerves, anxiety, tension or depression	1.40	1	0	0.0	0.00	1.00000	DENND1B
Impedance of arm (right)	1.39	2	0	0.0	0.00	1.00000	SH2B3 SLC9B1
Medication: Cholesterol lowering	1.38	1	0	0.0	0.00	1.00000	CARM1
Illnesses of father: Heart disease	1.36	1	0	0.0	0.00	1.00000	SH2B3
Medication: Lisinopril	1.36	1	0	0.0	0.00	1.00000	SH2B3
Ever smoked	1.36	2	0	0.0	0.00	1.00000	CCDC88B SH2B3
High blood pressure (siblings)	1.35	1	0	0.0	0.00	1.00000	SH2B3
Average weekly red wine intake	1.31	1	0	0.0	0.00	1.00000	GSDMB
Arm fat-free mass (left)	1.31	4	1	2.2	-0.02	0.97928	DDX6 IL12RB2 SH2B3 SYNGR1
Osteoporosis (self-reported)	1.30	1	0	0.0	0.00	1.00000	CCDC88B
Arm predicted mass (left)	1.28	3	1	2.2	0.00	1.00000	DDX6 SH2B3 SYNGR1
Loneliness, isolation	1.26	1	0	0.0	0.00	1.00000	SH2B3
Nervous feelings	1.25	1	0	0.0	0.00	1.00000	DENND1B
Arm predicted mass (right)	1.25	2	1	2.2	0.00	1.00000	SH2B3 SYNGR1
Illnesses of father: High blood pressure	1.24	1	0	0.0	0.00	1.00000	SH2B3
Arm fat-free mass (right)	1.23	2	1	2.2	0.00	1.00000	SH2B3 SYNGR1
Heel T-Score	1.22	8	1	2.2	-0.46	0.21698	CCDC88B DDX6 IL12A IL12RB2 IRF5 KPNA4 SMC4 TRIM59
Blood clot in the leg (DVT)	1.19	1	0	0.0	0.00	1.00000	SH2B3
Miserableness	1.18	1	0	0.0	0.00	1.00000	GSDMB
Trunk predicted mass	1.16	5	1	2.2	-0.38	0.52544	DDX6 IL12RB2 KPNA4 SH2B3 SYNGR1
Trunk fat-free mass	1.15	5	1	2.2	-0.39	0.52023	DDX6 IL12RB2 KPNA4 SH2B3 SYNGR1
Deep venous thrombosis (DVT) (self-reported)	1.14	1	0	0.0	0.00	1.00000	SH2B3
Chest pain or discomfort	1.13	1	0	0.0	0.00	1.00000	GSDMB
Depressed Affect (Nagel 2018)	1.09	1	0	0.0	0.00	1.00000	SH2B3
Worry (Nagel 2018)	1.08	1	0	0.0	0.00	1.00000	DENND1B
Maternal smoking around birth	1.08	1	0	0.0	0.00	1.00000	CCDC88B
Whole body water mass	1.08	4	1	2.2	-0.22	0.78182	DDX6 KPNA4 SH2B3 SYNGR1
Whole body fat-free mass	1.07	2	1	2.2	0.00	1.00000	SH2B3 SYNGR1
Impedance of whole body	1.05	1	0	0.0	0.00	1.00000	SLC9B1
Worrier / anxious feelings	1.04	1	0	0.0	0.00	1.00000	DENND1B
Smoking Status	1.03	1	0	0.0	0.00	1.00000	CCDC88B
Basal metabolic rate	1.02	3	1	2.2	0.00	1.00000	DDX6 SH2B3 SYNGR1
Birth weight	1.01	1	1	2.2	0.00	1.00000	SH2B3
Neuroticism	1.00	1	0	0.0	0.00	1.00000	DENND1B
Sensitivity / hurt feelings	0.99	1	0	0.0	0.00	1.00000	DENND1B
Waist Hip Ratio (WHR)	0.96	1	1	2.2	0.00	1.00000	SLC26A1
Neuroticism (Nagel 2018)	0.95	1	0	0.0	0.00	1.00000	DENND1B
Impedance of leg (right)	0.95	3	0	0.0	0.00	1.00000	DENND1B KPNA4 TRIM59
Leg fat percentage (right)	0.92	1	1	2.2	0.00	1.00000	SLC26A1
Leg fat percentage (left)	0.92	1	1	2.2	0.00	1.00000	SLC26A1
Hip circumference	0.90	2	0	0.0	0.00	1.00000	SH2B3 SYNGR1
Weight	0.89	2	0	0.0	0.00	1.00000	SH2B3 SYNGR1
Leg fat-free mass (right)	0.87	1	0	0.0	0.00	1.00000	SH2B3
Leg predicted mass (right)	0.86	1	0	0.0	0.00	1.00000	SH2B3
Waist circumference	0.85	1	1	2.2	0.00	1.00000	SLC26A1
Lung FVC	0.83	3	0	0.0	0.00	1.00000	DEXI GSDMB SH2B3
Body mass index (BMI)	0.82	1	0	0.0	0.00	1.00000	DENND1B
Leg fat mass (left)	0.82	1	0	0.0	0.00	1.00000	SLC26A1
Age when periods started (menarche)	0.81	1	0	0.0	0.00	1.00000	SLC9B1
Impedance of leg (left)	0.81	1	0	0.0	0.00	1.00000	DENND1B
Body fat percentage	0.81	1	1	2.2	0.00	1.00000	SLC26A1
Leg predicted mass (left)	0.79	1	0	0.0	0.00	1.00000	SH2B3
Leg fat mass (right)	0.79	1	0	0.0	0.00	1.00000	SLC26A1
Leg fat-free mass (left)	0.78	1	0	0.0	0.00	1.00000	SH2B3
Hand grip strength (right)	0.76	1	0	0.0	0.00	1.00000	IRF5
Lung FEV1/FVC ratio	0.75	2	1	2.2	0.00	1.00000	GSDMB IL7R
Trunk fat percentage	0.74	1	1	2.2	0.00	1.00000	SLC26A1
Whole body fat mass	0.74	1	0	0.0	0.00	1.00000	SLC26A1
Comparative height size at age 10	0.74	1	1	2.2	0.00	1.00000	SH2B3
Arm fat mass (left)	0.71	2	0	0.0	0.00	1.00000	DENND1B SLC26A1
Trunk fat mass	0.70	2	0	0.0	0.00	1.00000	SLC26A1 SYNGR1
Arm fat mass (right)	0.69	2	0	0.0	0.00	1.00000	DENND1B SLC26A1
Arm fat percentage (left)	0.65	1	1	2.2	0.00	1.00000	SLC26A1
Arm fat percentage (right)	0.62	1	1	2.2	0.00	1.00000	SLC26A1
BMI	0.56	1	0	0.0	0.00	1.00000	DENND1B
Sitting height	0.55	2	0	0.0	0.00	1.00000	CTSH RMI2
Forced vital capacity (FVC), Best measure	0.53	1	0	0.0	0.00	1.00000	CARM1
Standing height	0.46	4	1	2.2	-0.50	0.49824	CARM1 CTSH SH2B3 SYNGR1
Height	0.37	5	2	4.4	-0.22	0.71605	CARM1 IL7R INPP1 SH2B3 SYNGR1
Tanning	0.37	2	1	2.2	0.00	1.00000	SH2B3 SYNGR1
Hair Pigment	0.22	3	2	4.4	0.00	1.00000	CARM1 SH2B3 SYNGR1

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Brain Putamen basal ganglia	1	0.162	1.7
GTEx	Adrenal Gland	1	0.070	1.6
GTEx	Brain Cortex	2	0.196	1.6
GTEx	Brain Frontal Cortex BA9	1	0.110	1.6
GTEx	Breast Mammary Tissue (Male)	2	0.171	1.6
GTEx	Liver	0	0.000	1.6
GTEx	Small Intestine Terminal Ileum	0	0.000	1.6
GTEx	Uterus	0	0.000	1.6
The Cancer Genome Atlas	Glioblastoma Multiforme	3	0.303	1.6
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	1	0.093	1.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	2	0.387	1.6
GTEx	Adipose Subcutaneous	4	0.116	1.5
GTEx	Adipose Visceral Omentum	1	0.050	1.5
GTEx	Artery Aorta	1	0.034	1.5
GTEx	Artery Coronary	2	0.171	1.5
GTEx	Brain Caudate basal ganglia	1	0.110	1.5
GTEx	Brain Hippocampus	0	0.000	1.5
GTEx	Brain Hypothalamus	0	0.000	1.5
GTEx	Brain Nucleus accumbens basal ganglia	1	0.117	1.5
GTEx	Cells EBV-transformed lymphocytes	2	0.143	1.5
GTEx	Cells Transformed fibroblasts	6	0.145	1.5
GTEx	Colon Sigmoid	2	0.139	1.5
GTEx	Colon Transverse	2	0.098	1.5
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.5
GTEx	Esophagus Mucosa	1	0.031	1.5
GTEx	Esophagus Muscularis	1	0.031	1.5
GTEx	Heart Atrial Appendage	2	0.128	1.5
GTEx	Heart Left Ventricle	1	0.067	1.5
GTEx	Lung	4	0.142	1.5
GTEx	Nerve Tibial	1	0.024	1.5
GTEx	Ovary	1	0.112	1.5
GTEx	Pancreas	4	0.248	1.5
GTEx	Pituitary	2	0.181	1.5
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.5
GTEx	Skin Sun Exposed Lower leg	5	0.140	1.5
GTEx	Spleen	3	0.216	1.5
GTEx	Stomach	1	0.069	1.5
GTEx	Testis	2	0.064	1.5
GTEx	Vagina	0	0.000	1.5
GTEx	Whole Blood	6	0.306	1.5
NTR	Blood	6	0.251	1.5
YFS	Blood	6	0.130	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	1	0.062	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	2	0.187	1.5
The Cancer Genome Atlas	Colon Adenocarcinoma	2	0.100	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	3	0.150	1.5
The Cancer Genome Atlas	Lung Adenocarcinoma	2	0.070	1.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	4	0.164	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	3	0.186	1.5
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	2	0.295	1.5
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.5
The Cancer Genome Atlas	Stomach Adenocarcinoma	5	0.305	1.5
The Cancer Genome Atlas	Testicular Germ Cell Tumors	3	0.241	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	1	0.204	1.5
GTEx	Artery Tibial	2	0.054	1.4
GTEx	Brain Cerebellar Hemisphere	1	0.068	1.4
GTEx	Brain Cerebellum	1	0.051	1.4
GTEx	Breast Mammary Tissue	1	0.051	1.4
GTEx	Breast Mammary Tissue (Female)	1	0.062	1.4
GTEx	Muscle Skeletal	2	0.070	1.4
GTEx	Prostate	0	0.000	1.4
GTEx	Thyroid	1	0.025	1.4
METSIM	Adipose	3	0.066	1.4
CommonMind	Brain Pre-frontal Cortex	7	0.131	1.4
The Cancer Genome Atlas	Breast Invasive Carcinoma	3	0.070	1.4
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	3	0.113	1.4
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	3	0.075	1.4
The Cancer Genome Atlas	Brain Lower Grade Glioma	3	0.072	1.4
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	1	0.064	1.4
The Cancer Genome Atlas	Prostate Adenocarcinoma	3	0.067	1.4
The Cancer Genome Atlas	Thyroid Carcinoma	5	0.100	1.4
ROSMAP	Brain Pre-frontal Cortex	3	0.069	1.3
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.3